Screener
Palvella Therapeutics PVLA Prepaid & Other Current
Prepaid & Other Current at other companies
Other financials
Where this comes from
Reported directly by Palvella Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.
The source filing: Palvella Therapeutics’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 8:30 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-210463
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Current assets: | ||
| Cash and cash equivalents | $206,394 | $57,982 |
| Short-term investments | 55,459 | — |
| Prepaid expenses and other current assets | 1,378 | 1,005 |
| Total current assets | 263,231 | 58,987 |
| Operating lease right-of-use assets, net | 528 | 572 |
| Total assets | $263,759 | $59,559 |
| LIABILITIES AND STOCKHOLDERS' EQUITY |
Item 1. Financial Statements.
FAQ
- What is Palvella Therapeutics's prepaid & other current?
- Palvella Therapeutics (PVLA) reported prepaid & other current of $1.38M in Q1 2026.
- How has Palvella Therapeutics's prepaid & other current changed year-over-year?
- Palvella Therapeutics's prepaid & other current decreased by 24.9% year-over-year, from $1.84M to $1.38M.
- What is the long-term trend for Palvella Therapeutics's prepaid & other current?
- Over 5 years (2020 to 2025), Palvella Therapeutics's prepaid & other current has grown at a -22.4% compound annual growth rate (CAGR), from $3.58M to $1.01M.
- What does prepaid & other current mean?
- Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.
Ask your AI about Palvella Therapeutics's prepaid & other current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude